Fisher Asset Management
APYX icon

Fisher Asset Management’s Apyx Medical APYX Stock Holding History

Fisher Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,949
Closed -$33.6K – 1017
2025
Q2 		$33.6K Buy
+14,949
New +$21K ﹤0.01% 981

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management's APYX Position: Q3 2025 in Review

Fisher Asset Management sold out of Apyx Medical (APYX) in Q3 2025, closing a stake of 14,949 shares — an estimated $33.6K sold.

Fisher Asset Management first reported a position in APYX in Q2 2025 and held it in 1 quarter. The position peaked at $33.6K in Q2 2025. 47 funds tracked by Wall St. Rank hold APYX as of Q3 2025.

  • Fisher Asset Management reported no remaining Apyx Medical position as of Q3 2025 after selling out during the quarter.
  • Fisher Asset Management sold 14,949 Apyx Medical shares in Q3 2025, an estimated $33.6K.
  • Fisher Asset Management first reported a position in Apyx Medical in Q2 2025 and held it in 1 quarter.
  • Fisher Asset Management's Apyx Medical position peaked at $33.6K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.